There are currently no randomised controlled trials evaluating GLP-1 receptor agonists as a treatment for rheumatoid arthritis, and these medications are not licensed or recommended for this indication by the MHRA, NICE, or the European Medicines Agency (EMA)
This means they have not been formally assessed for safety, efficacy, or quality by the UK's medicines regulator (6)
The enzyme tyrosinase drives this process, and glutathione interferes with it in two important ways
If you are looking for a deeper dive into GLP-1 agonists and how they work, adverse effects, and drug interactions, take a listen to this podcast
If you eat balanced meals and do regular exercise, these things will work together with semaglutide
There is insufficient evidence regarding the safety of glutathione injection during pregnancy or breastfeeding